AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/590
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBailey, Men_US
dc.contributor.authorCorcoran, Ten_US
dc.contributor.authorSchug, Sen_US
dc.contributor.authorToner, Aen_US
dc.date2018-05-11-
dc.date.accessioned2018-06-15T05:50:15Z-
dc.date.available2018-06-15T05:50:15Z-
dc.identifier.citationEpub ahead of printen_US
dc.identifier.urihttp://hdl.handle.net/11055/590-
dc.description.abstractChronic post-surgical pain (CPSP) occurs in 12% of surgical populations and is a high priority for perioperative research. Systemic lidocaine may modulate several of the pathophysiological processes linked to CPSP. This systematic review aims to identify and synthesize the evidence linking lidocaine infusions and CPSP.The authors conducted a systematic literature search of the major medical databases from inception until October 2017. Trials that randomized adults without baseline pain to perioperative lidocaine infusion or placebo were included if they reported on CPSP. The primary outcome was the presence of procedure-related pain at three months or longer after surgery. The secondary outcomes of pain intensity, adverse safety events and local anesthetic toxicity were also assessed.Six trials from four countries (n=420) were identified. CPSP incidence was consistent with existing epidemiological data. Perioperative lidocaine infusions significantly reduced the primary outcome (odds ratio, 0.29; 95% CI, 0.18 to 0.48), although the difference in intensity of CPSP assessed by the short form McGill pain questionnaire (four trials) was not statistically significant (weighted mean difference, -1.55; 95% CI, -3.16 to 0.06). Publication and other bias were highly apparent, as were limitations in trial design. Each study included a statement reporting no adverse events attributable to lidocaine, but systematic safety surveillance strategies were absent.Current limited clinical trial data and biological plausibility support lidocaine infusions use to reduce the development of CPSP without full assurances as to its safety. This hypothesis should be addressed in future definitive clinical trials with comprehensive safety assessment and reporting.en_US
dc.titlePerioperative Lidocaine Infusions for the Prevention of Chronic Post-Surgical Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety.en_US
dc.typeJournal Articleen_US
dc.type.contentTexten_US
dc.identifier.journaltitlePainen_US
dc.identifier.doi10.1097/j.pain.0000000000001273en_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/29757886en_US
dc.contributor.anzcaaddBailey, Men_US
dc.contributor.anzcaaddCorcoran, Ten_US
dc.contributor.anzcaaddSchug, Sen_US
dc.contributor.anzcaaddToner, Aen_US
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Scholarly and Clinical
Show simple item record

Page view(s)

8
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.